Purchase Order 75N95D25P00073
- Not listed
- <p>The National Institute on Aging awarded a purchase order to Vizgen Inc. for $35,513.00 on May 6, 2026, to obtain MERSCOPE kits and panels for spatial transcriptomic experiments on fresh frozen ovary tissue using the MERSCOPE platform. Work is performed in Cambridge, Massachusetts, with completion by June 30, 2026. The order is priced as firm fixed price with no small business set-aside.</p>
- <p>The National Institutes of Health National Institute on Aging awarded Vizgen Inc. a $322,600 firm fixed price purchase order contract to provide a single-cell spatial genomics analyzer - Merscope platform. The place of performance is Cambridge, Massachusetts and the period of performance is from August 1, 2023 through September 30, 2023. The contract was set aside for total small business.</p>
- This is a $49,390 firm-fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Vizgen Inc., a for-profit manufacturer of spatial genomics technologies. The contract is for the delivery of Vizgen's Merscope FFPE (formalin-fixed, paraffin-embedded) sample preparation kits, slide boxes, and gene panels. This award does not utilize a set-aside designation. Vizgen is a small business registered in the...
- This is a $32,500 firm fixed price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the Department of Health and Human Services, to Vizgen Inc., a for-profit manufacturer of spatial genomics technologies. The contract is for maintenance and repair services for Vizgen's Merscope Spatial Transcriptomics Instrument, which supports the NIA's genomic research initiatives. Vizgen, a small business registered in SAM.gov, has previously received other federal...
- The Federal Contract Award with ID 75N98024P01235 was issued to Vizgen Inc., a for-profit manufacturer of spatial genomics technologies, by the Office of Logistics and Acquisition Operations, a civilian agency. The $4,180.00 firm-fixed-price purchase order is for the delivery of Vizgen's Merscope Spatial Genomic Transcriptor platform, FFPE sample preparation kits, slide boxes, and gene panels, as well as maintenance and repair services for the Merscope instrument. The award is not associated...
- The National Institute on Aging has awarded a delivery order valued at $162,361.29 to 10X Genomics, Inc. for the procurement of Visium HD spatial transcriptomics reagent materials and consumables. The delivery order, issued on August 14, 2025, covers Visium HD human transcriptome kits in 6.5 mm format (16 reactions) and dual index kit set A (96 reactions). This order was placed under 10X Genomics' existing indefinite delivery contract with the National Institute on Aging, a $7 million vehicle...
- Vizgen Inc., a for-profit manufacturer of advanced spatial genomics technologies, was awarded a $148,815 Firm Fixed Price Purchase Order contract by the National Institute on Drug Abuse (NIDA) to provide the MERSCOPE ULTRA PLATFORM, including purchase, installation, and training. The contract has an ultimate completion date of October 27, 2025 and does not utilize any set-aside designations. Vizgen's core offerings include genomic analysis instruments, sample preparation kits, gene panels, and...
- The Department of Health and Human Services National Institutes of Health Office of Logistics and Acquisition Operations awarded a $299,500 Definitive Contract to Vizgen Inc. as the Prime Contractor. The contract has a Place of Performance in Cambridge, Massachusetts and spans from August 17, 2022 through August 16, 2023. Vizgen Inc. will provide services to the agency on a Firm Fixed Price basis during this period. No subcontractors or additional context regarding products and services were...
- The National Institute on Aging awarded a $240,852.60 firm fixed-price delivery order to 10X Genomics, Inc. for biological and reagent materials, specifically GEM-X Universal 3' Gene Expression V4 gene expression kits and supplies for four samples. The award was issued on July 23, 2025, with an ultimate completion date of October 22, 2025, and carries no set-aside designation. Performance will be conducted at the contractor's facility in Pleasanton, California. This delivery order is issued...
- The National Institute on Aging awarded a $45,099 firm fixed-price delivery order to 10X Genomics, Inc. on September 18, 2025, for biological and reagent materials, specifically a human pan tissue and pathways assay kit. The contract carries no set-aside designation and is scheduled for completion by October 17, 2025. This delivery order is issued under 10X Genomics' larger indefinite delivery contract with NIA valued at up to $7 million through July 2029, which focuses on providing optimization...
The National Institute on Aging awarded a purchase order to Vizgen Inc. on August 28, 2025, with a ceiling value of $23,665 for in vitro diagnostic substances, reagents, test kits, and MERSCOPE equipment and reagents. This firm fixed-price contract, which carries an ultimate completion date of November 27, 2025, supports the agency's research initiatives through the procurement of specialized spatial genomics technology. The award was made without a set-aside designation and is being performed at Vizgen's facility in Cambridge, Massachusetts. Vizgen is an established provider of advanced spatial genomic transcriptor platforms and related analytical instruments to federal research agencies, particularly within the National Institutes of Health portfolio. The MERSCOPE system enables sophisticated single-cell and spatial transcriptomics research, capabilities that align with the National Institute on Aging's mission to support biomedical and behavioral research on aging processes and age-related diseases. This contract represents a continuation of Vizgen's established relationship with the National Institute on Aging, extending the agency's access to cutting-edge genomic analysis tools necessary for aging-focused research and scientific exploration.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.7k | 8/28/25 |